Skip to main content
. 2024 Feb 20;11(3):199. doi: 10.3390/bioengineering11030199
AF Atrial fibrillation
ATE Average treatment effect
BB Beta blocker
BF Bayes factor
CCB Calcium channel blocker
COPD Chronic obstructive pulmonary disease
HDI Highest density interval
ICU Intensive care unit
IQR Interquartile range
MgS Magnesium sulphate
NOAF New onset atrial fibrillation
OSA Obstructive sleep apnoe
PCB Potassium channel blocker